Abstract:γ-aminobutyric acid type A receptors (GABAARs) are the major mediators of synaptic inhibition in the brain. Aberrant GABAAR activity or regulation is observed in various neurodevelopmental disorders, neurodegenerative diseases and mental illnesses, including epilepsy, Alzheimer's and schizophrenia. Benzodiazepines, anesthetics and other pharmaceutics targeting these receptors find broad clinical use, but their inherent lack of receptor subtype specificity causes unavoidable side effects, raising a need for new or adjuvant medications. In this review article, we introduce a new strategy to modulate GABAeric signaling: targeting the intracellular protein interactors of GABAARs. Of special interest are scaffolding, anchoring and supporting proteins that display high GABAAR subtype specificity. Recent efforts to target gephyrin, the major intracellular integrator of GABAergic signaling, confirm that GABAAR-associated proteins can be successfully targeted through diverse molecules, including recombinant proteins, intrabodies, peptide-based probes and small molecules. Small-molecule artemisinins and peptides derived from endogenous interactors, that specifically target the universal receptor binding site of gephyrin, acutely affect synaptic GABAAR numbers and clustering, modifying neuronal transmission. Interference with GABAAR trafficking provides another way to modulate inhibitory signaling. Peptides blocking the binding site of GABAAR to AP2 increase the surface concentration of GABAAR clusters and enhance GABAergic signaling. Engineering of gephyrin binding peptides delivered superior means to interrogate neuronal structure and function. Fluorescent peptides, designed from gephyrin binders, enable live neuronal staining and visualization of gephyrin in the post synaptic sites with submicron resolution. We anticipate that in the future, novel fluorescent probes, with improved size and binding efficiency, may find wide application in super resolution microscopy studies, enlightening the nanoscale architecture of the inhibitory synapse. Broader studies on GABAAR accessory proteins and the identification of the exact molecular binding interfaces and affinities will advance the development of novel GABAAR modulators and following in vivo studies will reveal their clinical potential as adjuvant or stand-alone drugs.

Electrophysiology of ionotropic GABA receptors

Gaba(A) Receptor Mutations Associated with Generalized Epilepsies

Tonic GABA Inhibition in Hippocampal Dentate Granule Cells: Its Regulation and Function in Temporal Lobe Epilepsies

GABA(A) receptor diversity and pharmacology

Structure–Function Relationships of Glycine and GABAA Receptors and Their Interplay With the Scaffolding Protein Gephyrin

Discovering the Intriguing Properties of Extrasynaptic γ-Aminobutyric Acid Type A Receptors

Spontaneously opening GABAA receptors play a significant role in neuronal signal filtering and integration

Heteromeric GABA<sub>A</sub>receptor structures in positively-modulated active states

Regulation of Inhibitory Signaling at the Receptor and Cellular Level; Advances in Our Understanding of GABAergic Neurotransmission and the Mechanisms by Which It Is Disrupted in Epilepsy

Evolution of Neurotransmitter Gamma-Aminobutyric Acid, Glutamate and Their Receptors

Inhibitory Glycine Receptor

Transportation and Role of GABAA Receptor in Neurological Diseases

Smooth operator(s): dialing up and down neurotransmitter responses by G-protein regulators

Heteromeric GABAA receptor structures in positively-modulated active states

Targeting GABAAR-Associated Proteins: New Modulators, Labels and Concepts

Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels

Structure, function, and plasticity of GABA transporters

GABA Metabolism and Transport: Effects on Synaptic Efficacy

An excitatory GABA loop operating in vivo

Activation Mechanism of the Heterodimeric Gaba(B) Receptor

Glutamate Receptor Ion Channels: Structure, Regulation, and Function